Showing results (891-900 of 6,317) with videos related to
Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|September 9, 2022
Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trialJoão Sérgio Neves, Francisco Vasques-Nóvoa, Marta Borges-Canha, et al.Diabetes, Obesity & Metabolism|September 2, 2022
A randomized, double-blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and womenChristian R Juhl, Josephine Burgdorf, Cecilie Knudsen, et al.Diabetes, Obesity & Metabolism|October 22, 2021
Patterns of insulin therapy and insulin daily doses in children and adolescents with type 1 diabetes in GermanyLouisa van den Boom, Karel KostevDiabetes, Obesity & Metabolism|February 16, 2022
Effect of bremelanotide on body weight of obese women: Data from two phase 1 randomized controlled trialsCarl Spana, Robert Jordan, Steven FischkoffDiabetes, Obesity & Metabolism|October 4, 2021
A novel hypothesis linking low-grade ketonaemia to cardio-renal benefits with sodium-glucose cotransporter-2 inhibitorsPreethika Ekanayake, Sunder MudaliarDiabetes, Obesity & Metabolism|October 4, 2021
Ultra-rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early phase studyJennifer Leohr, Christof Kazda, Rong Liu, et al.Diabetes, Obesity & Metabolism|February 15, 2022
Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomesSabine Kahl, Anne Pernille Ofstad, Bernard Zinman, et al.Diabetes, Obesity & Metabolism|May 16, 2019
Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross-over, randomized, double-blind, controlled inpatient physiology studyDario Tuccinardi, Olivia M Farr, Jagriti Upadhyay, et al.Diabetes, Obesity & Metabolism|April 20, 2019
Residual cardiovascular risk among people with diabetesSatya Dash, Lawrence A LeiterDiabetes, Obesity & Metabolism|October 18, 2018
Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT)Patrick Lee, Bruce R Yacyshyn, Mary B YacyshynPageof 632